Results 1 to 10 of about 1,216,392 (304)

Publisher’s Note: We Changed Page Numbers to Article Numbers for Articles Published in Infectious Disease Reports Volume 1 to Volume 12, Issue s1

Infectious Disease Reports, 2022
Infectious Disease Reports [...]
Infectious Disease Reports Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Infectious Disease Reports in 2021

Infectious Disease Reports, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Infectious Disease Reports Editorial Office
doaj   +1 more source

Acknowledgment to the Reviewers of Infectious Disease Reports in 2022

Infectious Disease Reports, 2023
High-quality academic publishing is built on rigorous peer review [...]
Infectious Disease Reports Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Tropical Medicine and Infectious Disease in 2020

Tropical Medicine and Infectious Disease, 2021
Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Tropical Medicine and Infectious Disease maintains its standards for the high quality of its published papers [...]
Tropical Medicine Infectious Disease Editorial Office
doaj   +1 more source

Guideline for imaging diagnosis of novel coronavirus (2019-ncov) infected pneumonia (1st edition 2020) [PDF]

Yixue xinzhi zazhi, 2020
Without the.
People's medical publishing House, Committee of the Infectious Diseases Radiology Group of Chinese Society of Radiology, Committee of the Infectious Diseases Radiology Section of Chinese Medical Doctor Association, Infectious Disease Imaging Group, Infectious Disease Branch, Chinese Research Hospital Association, Imaging Committee of Chinese Association for the Prevention and Treatment of STD AIDS Infection (Infectious Disease), Infectious Diseases Group, General Radiological Equipment Committee, China Association of Medical Equipment, Beijing Imaging Diagnosis and Treatment Technology Innovation Alliance   +10 more
doaj   +1 more source

Trends in recent waterborne and foodborne disease outbreaks in South Korea, 2015–2019 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives This study analyzed trends in foodborne and waterborne diseases in South Korea between 2015 and 2019. Methods The data consisted of information on outbreaks of waterborne and foodborne infectious diseases reported through the Korea Centers for
Sang Hyuk Lee, Jae-Won Yun, Ji Hee Lee, Yeon Haw Jung, Dong Han Lee   +4 more
doaj   +1 more source

The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing

Mediators of Inflammation, 2023
Background/Aims. The underlying mechanisms of differential responsiveness to IFN remain poorly understood. The elongation factor Tu GTP binding domain-containing protein 2 (EFTUD2), involved in RNA splicing and pre-mRNA processing, was recognized as a ...
Pingping Hu, Yuwen Li, Wen Zhang, Rui Liu, Linya Peng, Ruirui Xu, Jinyuan Cai, Hui Yuan, Tiantong Feng, Anran Tian, Ming Yue, Jun Li, Wenting Li, Chuanlong Zhu   +13 more
doaj   +1 more source

Screening for Latent Tuberculosis Infection using Interferon-Gamma Release Assay Test among Healthcare Workers

Global Medical & Health Communication, 2023
Healthcare workers (HCWs) represent a significant demographic for screening latent tuberculosis infection (LTBI) due to their potential exposure to infectious patients.
Rosamarlina Rosamarlina, Nina Mariana, Titi Sundari, Tri Yuli Setianingsih, Jahiroh Jahiroh, Intan Pertiwi, Aninda Dinar Widiantari, Vivi Setiawaty, Farida Murtiani   +8 more
doaj   +1 more source

Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening

Scientific Reports, 2022
We performed a high-throughput phenotypic whole cell screen of Mycobacterium tuberculosis against a diverse chemical library of approximately 100,000 compounds from the AbbVie corporate collection and identified 24 chemotypes with anti-tubercular ...
Anuradha Kumar, Somsundaram Chettiar, Brian S. Brown, Julie Early, Juliane Ollinger, Megan Files, Mai A. Bailey, Aaron Korkegian, Devon Dennison, Matthew McNeil, James Metz, Augustine Osuma, Michael Curtin, Aaron Kunzer, Gail Freiberg, Milan Bruncko, Dale Kempf, Tanya Parish   +17 more
doaj   +1 more source

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

Clinical and Translational Science, 2021
Tocilizumab is an IL‐6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2).
Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky, Vishal Didwania, Michael Anderson, Melina Diaz, Kairav Shah, Vishnu V. Chundi, David W. Hines, Brian P. Harting, Kamo Sidwha, Brian Yu, Paul Brune, Anjum Owaisi, David Beezhold, Joseph Kent, Dana Vais, Alice Han, Neethi Gowda, Nishi Sahgal, Jan Silverman, Jonathan Stake, Jenie Nepomuceno, Renuka Heddurshetti   +25 more
doaj   +1 more source